Bilić Sally Sophie, Moessner Markus, Wirtz Gustav, Lang Stephan, Weisbrod Matthias, Bauer Stephanie
Center for Psychotherapy Research, University Hospital Heidelberg, Heidelberg, Germany.
Center for Psychotherapy Research, University Hospital Heidelberg, Heidelberg, Germany.
Psychiatry Res. 2020 Jan 11;285:112771. doi: 10.1016/j.psychres.2020.112771.
Preventing readmission after hospital discharge is a major issue with regard to the continuity of patients' recovery process and the financial burden on the healthcare system, but adequate aftercare services are lacking. Therefore, a pilot study was conducted to examine the feasibility and acceptability of an Internet-based aftercare program for patients with personality disorders (PD) and / or trauma-related disorders as well as to obtain a preliminary estimate of effects on symptomatology and readmission. Patients' satisfaction with the program and symptomatology (KPD-38, BDI-II) were assessed prior to hospital discharge (t) and after three months of participation (t). Log data on program utilization (i.e., logins, page hits, and chat use) were automatically assessed via server logs. N = 31 of 45 eligible patients consented to participate. 84% used the intervention at least once. The average duration of participation was 63 days (SD = 4.6). Patients attended on average 7.2 out of 12 group chat sessions (SD = 4.0). Findings indicate very high acceptance of and satisfaction with the intervention. Symptomatology on all outcomes was stable, no deteriorations could be observed. 20% reported readmission within the aftercare period. Efficacy and cost-effectiveness should be tested with a large-scale randomized controlled trial.
预防患者出院后的再入院是关乎患者康复进程的连续性以及医疗系统财务负担的一个重大问题，但目前缺乏充分的后续护理服务。因此，开展了一项试点研究，以检验针对人格障碍（PD）和/或创伤相关障碍患者的基于互联网的后续护理项目的可行性和可接受性，并初步评估其对症状和再入院情况的影响。在患者出院前（t）和参与项目三个月后（t）评估患者对该项目的满意度和症状（KPD - 38，BDI - II）。通过服务器日志自动评估项目使用的日志数据（即登录、页面点击量和聊天使用情况）。45名符合条件的患者中有31名同意参与。84%的患者至少使用过一次该干预措施。平均参与时长为63天（标准差 = 4.6）。患者平均参加了12次小组聊天中的7.2次（标准差 = 4.0）。研究结果表明患者对该干预措施的接受度和满意度非常高。所有结果的症状表现都很稳定，未观察到恶化情况。20%的患者在后续护理期间报告再次入院。应通过大规模随机对照试验来检验该项目的疗效和成本效益。
